Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions
The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated matern...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2021-04, Vol.397 (10281), p.1316-1324 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1324 |
---|---|
container_issue | 10281 |
container_start_page | 1316 |
container_title | The Lancet (British edition) |
container_volume | 397 |
creator | Van de Perre, Philippe Goga, Ameena Ngandu, Nobubelo Nagot, Nicolas Moodley, Dhayendre King, Rachel Molès, Jean-Pierre Mosqueira, Beatriz Chirinda, Witness Scarlatti, Gabriella Tylleskär, Thorkild Dabis, François Gray, Glenda |
description | The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies. |
doi_str_mv | 10.1016/S0140-6736(21)00570-5 |
format | Article |
fullrecord | <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_03274638v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A657133291</galeid><els_id>S0140673621005705</els_id><sourcerecordid>A657133291</sourcerecordid><originalsourceid>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</originalsourceid><addsrcrecordid>eNqFkctu1DAUhiMEotPCI4AsIaF2EfDdCRs0qgpTaSQWXMTOcpyTGVeJPdjJCN6-TlNmwQZvjnX0ndv_F8Urgt8RTOT7r5hwXErF5CUlVxgLhUvxpFgRrngpuPr5tFidkLPiPKU7jDGXWDwvzhirCOU1XhXhpneD82Z0focOIY35a3q0uf2Bxmh8GlxKLnjkPNq73T5H61rwFpCJYNIH5AFa1IWIbBgOPQzgRxP_oMaFAVpncy_nR4jHnM990oviWWf6BC8f40Xx_dPNt-tNuf3y-fZ6vS2tEGosGeVcAQhoa2OBGkM7gVmNO9zIisqqaxg1THIjKWltU7fSGtpY0uKuMqJS7KK4WvruTa8P0Q15KR2M05v1Vs85zKjiklVHktnLhT3E8GuCNOp8tYW-Nx7ClDQVuMovh4y--Qe9C1P0-ZKZUjXngszU24XamR50lixkCX6POzOlpPVaCkUYo_U8WSygjSGlCN1pVYL1bLN-sFnPHmpK9IPNWuS6149rTE2W-VT119cMfFwAyBofHUSdrJtta10EO-o2uP-MuAd8BLa5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2507944510</pqid></control><display><type>article</type><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><source>Elsevier ScienceDirect Journals</source><creator>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</creator><creatorcontrib>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</creatorcontrib><description>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(21)00570-5</identifier><identifier>PMID: 33812490</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Antibodies ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Breast feeding ; Breastfeeding & lactation ; Children & youth ; Condoms ; Disease transmission ; Highly active antiretroviral therapy ; HIV ; HIV (Viruses) ; Human immunodeficiency virus ; Immunoprophylaxis ; Infants ; Infections ; Life Sciences ; Medical colleges ; Medical tests ; Obstetrics ; Pediatrics ; Pregnancy ; Prevention ; Prophylaxis ; Santé publique et épidémiologie ; Womens health ; World health</subject><ispartof>The Lancet (British edition), 2021-04, Vol.397 (10281), p.1316-1324</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</citedby><cites>FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</cites><orcidid>0000-0002-0085-3498 ; 0000-0002-6863-6350 ; 0000-0003-4801-4324</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0140673621005705$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33812490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03274638$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Van de Perre, Philippe</creatorcontrib><creatorcontrib>Goga, Ameena</creatorcontrib><creatorcontrib>Ngandu, Nobubelo</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>King, Rachel</creatorcontrib><creatorcontrib>Molès, Jean-Pierre</creatorcontrib><creatorcontrib>Mosqueira, Beatriz</creatorcontrib><creatorcontrib>Chirinda, Witness</creatorcontrib><creatorcontrib>Scarlatti, Gabriella</creatorcontrib><creatorcontrib>Tylleskär, Thorkild</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>Gray, Glenda</creatorcontrib><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</description><subject>Age</subject><subject>Antibodies</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Breast feeding</subject><subject>Breastfeeding & lactation</subject><subject>Children & youth</subject><subject>Condoms</subject><subject>Disease transmission</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>Human immunodeficiency virus</subject><subject>Immunoprophylaxis</subject><subject>Infants</subject><subject>Infections</subject><subject>Life Sciences</subject><subject>Medical colleges</subject><subject>Medical tests</subject><subject>Obstetrics</subject><subject>Pediatrics</subject><subject>Pregnancy</subject><subject>Prevention</subject><subject>Prophylaxis</subject><subject>Santé publique et épidémiologie</subject><subject>Womens health</subject><subject>World health</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkctu1DAUhiMEotPCI4AsIaF2EfDdCRs0qgpTaSQWXMTOcpyTGVeJPdjJCN6-TlNmwQZvjnX0ndv_F8Urgt8RTOT7r5hwXErF5CUlVxgLhUvxpFgRrngpuPr5tFidkLPiPKU7jDGXWDwvzhirCOU1XhXhpneD82Z0focOIY35a3q0uf2Bxmh8GlxKLnjkPNq73T5H61rwFpCJYNIH5AFa1IWIbBgOPQzgRxP_oMaFAVpncy_nR4jHnM990oviWWf6BC8f40Xx_dPNt-tNuf3y-fZ6vS2tEGosGeVcAQhoa2OBGkM7gVmNO9zIisqqaxg1THIjKWltU7fSGtpY0uKuMqJS7KK4WvruTa8P0Q15KR2M05v1Vs85zKjiklVHktnLhT3E8GuCNOp8tYW-Nx7ClDQVuMovh4y--Qe9C1P0-ZKZUjXngszU24XamR50lixkCX6POzOlpPVaCkUYo_U8WSygjSGlCN1pVYL1bLN-sFnPHmpK9IPNWuS6149rTE2W-VT119cMfFwAyBofHUSdrJtta10EO-o2uP-MuAd8BLa5</recordid><startdate>20210403</startdate><enddate>20210403</enddate><creator>Van de Perre, Philippe</creator><creator>Goga, Ameena</creator><creator>Ngandu, Nobubelo</creator><creator>Nagot, Nicolas</creator><creator>Moodley, Dhayendre</creator><creator>King, Rachel</creator><creator>Molès, Jean-Pierre</creator><creator>Mosqueira, Beatriz</creator><creator>Chirinda, Witness</creator><creator>Scarlatti, Gabriella</creator><creator>Tylleskär, Thorkild</creator><creator>Dabis, François</creator><creator>Gray, Glenda</creator><general>Elsevier Ltd</general><general>Elsevier B.V</general><general>Elsevier Limited</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-0085-3498</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0003-4801-4324</orcidid></search><sort><creationdate>20210403</creationdate><title>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</title><author>Van de Perre, Philippe ; Goga, Ameena ; Ngandu, Nobubelo ; Nagot, Nicolas ; Moodley, Dhayendre ; King, Rachel ; Molès, Jean-Pierre ; Mosqueira, Beatriz ; Chirinda, Witness ; Scarlatti, Gabriella ; Tylleskär, Thorkild ; Dabis, François ; Gray, Glenda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c557t-32447ee5ed9ace2aa2f50390f0b68268fb32a364a621dcb9d6ca2bc1d0f8a5873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Antibodies</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Breast feeding</topic><topic>Breastfeeding & lactation</topic><topic>Children & youth</topic><topic>Condoms</topic><topic>Disease transmission</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>Human immunodeficiency virus</topic><topic>Immunoprophylaxis</topic><topic>Infants</topic><topic>Infections</topic><topic>Life Sciences</topic><topic>Medical colleges</topic><topic>Medical tests</topic><topic>Obstetrics</topic><topic>Pediatrics</topic><topic>Pregnancy</topic><topic>Prevention</topic><topic>Prophylaxis</topic><topic>Santé publique et épidémiologie</topic><topic>Womens health</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van de Perre, Philippe</creatorcontrib><creatorcontrib>Goga, Ameena</creatorcontrib><creatorcontrib>Ngandu, Nobubelo</creatorcontrib><creatorcontrib>Nagot, Nicolas</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>King, Rachel</creatorcontrib><creatorcontrib>Molès, Jean-Pierre</creatorcontrib><creatorcontrib>Mosqueira, Beatriz</creatorcontrib><creatorcontrib>Chirinda, Witness</creatorcontrib><creatorcontrib>Scarlatti, Gabriella</creatorcontrib><creatorcontrib>Tylleskär, Thorkild</creatorcontrib><creatorcontrib>Dabis, François</creatorcontrib><creatorcontrib>Gray, Glenda</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News & ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van de Perre, Philippe</au><au>Goga, Ameena</au><au>Ngandu, Nobubelo</au><au>Nagot, Nicolas</au><au>Moodley, Dhayendre</au><au>King, Rachel</au><au>Molès, Jean-Pierre</au><au>Mosqueira, Beatriz</au><au>Chirinda, Witness</au><au>Scarlatti, Gabriella</au><au>Tylleskär, Thorkild</au><au>Dabis, François</au><au>Gray, Glenda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2021-04-03</date><risdate>2021</risdate><volume>397</volume><issue>10281</issue><spage>1316</spage><epage>1324</epage><pages>1316-1324</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><abstract>The rate of mother-to-child transmission (MTCT) of HIV from breastfeeding is increasing relative to other causes of MTCT. Early effective preconception and antenatal antiretroviral therapy (ART) reduces intrauterine and intrapartum MTCT, whereas maternal post-partum HIV acquisition, untreated maternal HIV, and suboptimal postnatal maternal ART adherence increase the risk of MTCT through breastfeeding. Although the absolute number of cases of MTCT acquired through breastfeeding is decreasing, the rate of decrease is less than the decrease in intrauterine and intrapartum MTCT. Unless current strategies are universally applied, they might not be sufficient to eliminate MTCT due to breastfeeding. Urgent action is needed to evaluate and implement additional preventive biomedical strategies in high HIV prevalence and incidence settings to eliminate MTCT from breastfeeding. Preventive strategies include: pre-exposure prophylaxis in breastfeeding women who have an increased risk of acquiring HIV; postnatal reinforcement strategies, such as maternal retesting for HIV, maternal care reinforcement, and prophylaxis in infants exposed to HIV via breastmilk; and active (vaccine) or passive immunoprophylaxis with long-acting broadly neutralising antibodies.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33812490</pmid><doi>10.1016/S0140-6736(21)00570-5</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0085-3498</orcidid><orcidid>https://orcid.org/0000-0002-6863-6350</orcidid><orcidid>https://orcid.org/0000-0003-4801-4324</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0140-6736 |
ispartof | The Lancet (British edition), 2021-04, Vol.397 (10281), p.1316-1324 |
issn | 0140-6736 1474-547X |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_03274638v1 |
source | Elsevier ScienceDirect Journals |
subjects | Age Antibodies Antiretroviral agents Antiretroviral drugs Antiretroviral therapy Breast feeding Breastfeeding & lactation Children & youth Condoms Disease transmission Highly active antiretroviral therapy HIV HIV (Viruses) Human immunodeficiency virus Immunoprophylaxis Infants Infections Life Sciences Medical colleges Medical tests Obstetrics Pediatrics Pregnancy Prevention Prophylaxis Santé publique et épidémiologie Womens health World health |
title | Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eliminating%20postnatal%20HIV%20transmission%20in%20high%20incidence%20areas:%20need%20for%20complementary%20biomedical%20interventions&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Van%20de%20Perre,%20Philippe&rft.date=2021-04-03&rft.volume=397&rft.issue=10281&rft.spage=1316&rft.epage=1324&rft.pages=1316-1324&rft.issn=0140-6736&rft.eissn=1474-547X&rft_id=info:doi/10.1016/S0140-6736(21)00570-5&rft_dat=%3Cgale_hal_p%3EA657133291%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2507944510&rft_id=info:pmid/33812490&rft_galeid=A657133291&rft_els_id=S0140673621005705&rfr_iscdi=true |